Welcome!

News Feed Item

The Worldwide Market for Molecular Diagnostics 6-month Update

NEW YORK, March 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Worldwide Market for Molecular Diagnostics 6-month Update
http://www.reportlinker.com/p02051943/The-Worldwide-Market-for-Molecular-Diagnostics-6-month-Update.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.

In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July – December. This report highlights trends and developments that portent the evolution of molecular tests and technologies. The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.

Though focused on the developments of the last six months, coverage is substantial.

As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:

-Microbiology
-Histology
-Blood Screening
-Prenatal
-Coagulation
-Inherited Diseases
-Tissue Typing
-Cancer Markers
-Pharmacodiagnostics
- CTCs

The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations.

In addition the following important trend information is also provided:

-Selected Sequencing-Based Innovations July-December 2013
-Selected Molecular Diagnostics Collaborations, July-December 2013
-Selected Molecular Diagnostics Licensing Agreements, July-December 2013
-Selected Molecular Diagnostics Distribution Agreements, July-December 2013
-Regulatory and Reimbursement Update
-Molecular Test Revenues of The Top Companies, 2012-2013

Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.
CHAPTER ONE: MARKET OVERVIEW
Background
Scope and Methodology
Size And Growth Of The Market, Worldwide
Regulatory and Reimbursement Update
Company Moves
Top Suppliers and Niche players
Test Services Continue to Expand

Point of View
CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Background
Cancer gets more personal
Pathogen sequencing
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Background
Blood-based analyses
Circulating Tumor Cells
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Background
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Background
Coagulation Market Analysis
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Background
Molecular Histology
Market Analysis
HPV Testing
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Overview
HIV/AIDS
Hepatitis
Sexually Transmitted Diseases
Hospital Acquired Infections
Respiratory Tract Infections

Tuberculosis
Blood Culture
Miscellaneous
Mass Spectrometry
CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER TEN: The Market For Molecular Assays For Inherited Diseases
Market Analysis
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant
Management
Market Analysis
CHAPTER TWELVE: The Market For Molecular Assays
In Prenatal And Neonatal Testing
Market Analysis
CHAPTER THIRTEEN: Forecast: An Eye For The Next Six Months
– January To June 2014
Market Analysis

List of Tables

CHAPTER ONE: MARKET OVERVIEW
Table 1-1: Exchange Rate Fluctuations, 2009-2013
Table 1-2: Worldwide Molecular Test Sales, 2012-2013, by Test Segment (Growth Rates in
Molecular Diagnostics Compared (Microbiology, Histology, Blood Screening, Prenatal,
Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-4: Selected Advanced Test Innovations, July –December 2013
Table 1-5: Selected Company Purchases And Joint Ventures, July-December 2013
Table 1-6: Selected collaborations, July-December 2013
Table 1-7: Selected licensing agreements, July-December 2013
Table 1-8: Selected distribution agreements, July-December 2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012-2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012 Vs. 2013
Table 1-10: Selected Molecular Test Services, Sales 2012-2013
Table 1-11: Selected Molecular Test Services, July-December 2013

CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Table 2-1: Major Sequencing Platforms
Table 2-2: Selected Sequencing-Based Innovations July-December 2013
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Table 3-1: Selected Innovation In Blood-Based Cancer Tests, July-December 2013
Table 3-2: Selected Non-Invasive Molecular Cancer Tests In Development, July-December 2013
Table 3-3: Selected Innovations In Circulating Tumor Cell Testing, July-December 2013
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Table 4-1: Selected Innovations In Molecular Hematological Tests, July-December 2013
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Table 5-1: Selected Tests For Coagulation And Cardiac Disease Molecular Markers July- December 2013
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Table 6-1: Worldwide Molecular Histology/Cytology Sales, 2012-2013
Table 6-2: Selected Molecular Histology Innovations, July-December 2013
Table 6-3: Selected Innovations In Molecular Tissue Sample Preparation, July – December 2013
Table 6-4: Selected Innovations In HPV Testing, July –December 2013
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Table 7-1: Molecular Test Sales, Microbiolog/Virology, 2012-2013
Table 7-2: Selected Hepatitis Test Innovations, July-December 2013
Table 7-3: Selected Innovations In Molecular STD Testing, July-December 2013
Table 7-4: Selected Molecular HAI Test Innovations, July-December 2013
Table 7-5: Selected Respiratory Tract Test Innovations, July-December 2013
Table 7-6: Selected Microbiology Innovations, July-December 2013
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
Table 9-1: Selected Innovations In Molecular Tests For Inherited Diseases, July – December 2013
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant Management
Table 11-1: Selected Innovations In Prenatal Testing, July-December 2013

To order this report: The Worldwide Market for Molecular Diagnostics 6-month Update
http://www.reportlinker.com/p02051943/The-Worldwide-Market-for-Molecular-Diagnostics-6-month-Update.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Dhiraj Sehgal works in Delphix's product and solution organization. His focus has been DevOps, DataOps, private cloud and datacenters customers, technologies and products. He has wealth of experience in cloud focused and virtualized technologies ranging from compute, networking to storage. He has spoken at Cloud Expo for last 3 years now in New York and Santa Clara.
HyperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let's say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it...
In his keynote at 19th Cloud Expo, Sheng Liang, co-founder and CEO of Rancher Labs, discussed the technological advances and new business opportunities created by the rapid adoption of containers. With the success of Amazon Web Services (AWS) and various open source technologies used to build private clouds, cloud computing has become an essential component of IT strategy. However, users continue to face challenges in implementing clouds, as older technologies evolve and newer ones like Docker c...
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world.
"We're focused on how to get some of the attributes that you would expect from an Amazon, Azure, Google, and doing that on-prem. We believe today that you can actually get those types of things done with certain architectures available in the market today," explained Steve Conner, VP of Sales at Cloudistics, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Sanjeev Sharma Joins November 11-13, 2018 @DevOpsSummit at @CloudEXPO New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more than 24 years of IT Operations experience with a focus on highly-scalable architectures.
JETRO showcased Japan Digital Transformation Pavilion at SYS-CON's 21st International Cloud Expo® at the Santa Clara Convention Center in Santa Clara, CA. The Japan External Trade Organization (JETRO) is a non-profit organization that provides business support services to companies expanding to Japan. With the support of JETRO's dedicated staff, clients can incorporate their business; receive visa, immigration, and HR support; find dedicated office space; identify local government subsidies; get...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
DXWorldEXPO LLC announced today that Dez Blanchfield joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Dez is a strategic leader in business and digital transformation with 25 years of experience in the IT and telecommunications industries developing strategies and implementing business initiatives. He has a breadth of expertise spanning technologies such as cloud computing, big data and analytics, cognitive computing, m...